Replies to post #50316 on Therapeutic Solutions International Inc (TSOI)

[cablejohn]

TSOI IS COVERING THEIR ASSET... BIG THINGS GOING ON!!!

[Sctrben]

Hmmm COVID isn’t history, it just the frog in boiling water as we get used to it in all its new forms showing up. As for other applications, ARDS is highlighted and I know we talked about COPD. Not just a COVID play as it had a market prior

[HIFI]

Yes they are, people lungs are damaged from covid I know someone who has had covid almost died and it's been 6 months his lungs are still bad

JadiCell can be used for many lung problems

This pivotal trial has significant implications not only to COVID-19 patients with severe lung compromise but also the significant population of patients suffering from acute respiratory distress syndrome (ARDS)," said Dr. Thomas Ichim, Director of the Company. "If the trial is successful, we anticipate FDA registration of JadiCell as the first cell based therapeutic to address ARDS which represents a multibillion-dollar market."